Novo Nordisk has priced a CHF denominated multi tranche syndicated Alpine Bond.
For all the deals placed in the market today use the Bond Market or Money Market Viewers.
| Issuer Details | |
| Issuer | Novo Nordisk A/S |
| LEI | 549300DAQ1CVT6CXN342 |
| Industry | Pharmaceuticals |
| Country | Denmark |
| Issuer Description | Novo Nordisk is a Denmark-based company. It is engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company reports two business segments: Diabetes and Biopharmaceuticals. Diabetes division offers a range of diabetes products, including modern insulins, Biopharmaceuticals division provides treatments for people with haemophilia, growth hormone deficiency and for women experiencing symptoms of menopause / 08.12 |
| Generic Credit Rating | [Login to see full details] |
| Trade Details | |
| Security Type | Bond |
| Amount | CHF [Login to see full details] |
| Total Amount including taps | CHF [Login to see full details] |
| Total Amount Outstanding | CHF [Login to see full details] |
| Total Order Book | CHF [Login to see full details] |
| Structure | Fixed Rate |
| Coupon | [Login to see full details] |
| Reoffer | [Login to see full details] |
| Term | [Login to see full details] |
| Trade Date | [Login to see full details] |
| Settlement Date | [Login to see full details] |
| Maturity Date | [Login to see full details] |
| Yield Notes | [Login to see full details] |
Login to see if this deal qualifies as a Green Bond or Social Bond or other type of ESG Bond.
An Alpine bond is a CHF-denominated bond issued by a non-Swiss entity in the Swiss Foreign Bond market.
Check here for all issuer’s year to date financings.